OY4 fund - quotient blood typing reagents
Active Awarded Last action
- Contract number
- 36C25726N0224
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,514
Award facts
- Contract value 100% obligated
- $16,514.42 Current and potential, with all options
- Completion date 56% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60607, USA
Award details come from SAM.gov/FPDS.
About this award
Alba Bioscience, Inc., a Chicago-based diagnostics company specializing in blood banking reagents, received a $16.5K task order call under a Blanket Purchase Agreement with Veterans Integrated Service Network 17 for Quotient blood typing reagents. The award, issued on April 1, 2026, is structured as a firm fixed-price BPA call without set-aside designation, with performance expected through March 31, 2027. This procurement falls under GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, enabling the VA facility to procure critical immunohematology supplies through streamlined ordering processes.
Alba Bioscience's blood typing reagent portfolio includes monoclonal antibodies, antibody identification and screening panels, quality control kits, and specialized cell reagents necessary for transfusion services and diagnostic testing. The company maintains established BPAs across multiple VA Networks, having demonstrated sustained performance as a specialized supplier of blood banking materials to the Department of Veterans Affairs and other federal healthcare systems. This task order represents one of numerous call orders positioned to support diagnostic and transfusion operations across VA medical facilities nationwide, reflecting the routine procurement of essential immunohematology products required for patient care delivery.
Quick answers
Who was awarded contract 36C25726N0224?
36C25726N0224 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on April 1, 2026.
How much is contract 36C25726N0224 worth?
The government has obligated $16,514 on 36C25726N0224.
Is contract 36C25726N0224 an order under another contract?
Yes. 36C25726N0224 is a BPA call under 36F79721D0259-36C25722A0018, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25726N0224 competed?
The extent of competition for 36C25726N0224 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award